Who Owns Nuvectis Pharma Stock?
NASDAQ: NVCTHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 33.57%
- Held by insiders
- 34.43%
- Institutional holders
- 115
- Institutions 33.6%
- Insiders 34.4%
- Public and other 32.0%
Who owns Nuvectis Pharma stock?
Institutional investors own about 33.6% of Nuvectis Pharma's shares, spread across 115 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 34.43% of NVCT.
The largest institutional holders are Tang Capital Management, LLC (4.75%), Blackrock Inc. (3.07%) and Soleus Capital Management, L.P. (3.06%). Together, the top 10 institutions control 23.7% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their NVCT positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of NVCT
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Tang Capital Management, LLC | 1.55M | 4.75% | +100.0% |
| Blackrock Inc. | 1.00M | 3.07% | +31.0% |
| Soleus Capital Management, L.P. | 1.00M | 3.06% | +100.0% |
| Perceptive Advisors Llc | 1.00M | 3.06% | +100.0% |
| Vanguard Capital Management LLC | 872.48K | 2.67% | +32.2% |
| Iridian Asset Management LLC | 777.08K | 2.38% | +19.2% |
| Geode Capital Management, LLC | 432.27K | 1.32% | +12.5% |
| Sphera Funds Management Ltd. | 382.94K | 1.17% | +100.0% |
| Baldwin Wealth Partners LLC/MA | 382.01K | 1.17% | +0.9% |
| Occam Crest Management LP | 357.15K | 1.09% | -12.3% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of NVCT
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 482.09K | 1.48% |
| iShares Trust-iShares Russell 2000 ETF | 430.82K | 1.32% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 198.56K | 0.61% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 187.29K | 0.57% |
| iShares Trust-iShares Russell 2000 Growth ETF | 161.77K | 0.50% |
| Fidelity Covington Trust-Fidelity Enhanced Small Cap Core ETF | 97.12K | 0.30% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 86.79K | 0.27% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 79.74K | 0.24% |
| iShares Trust-iShares Micro-Cap ETF | 57.75K | 0.18% |
| iShares Trust-iShares Core S&P Total U.S. Stock Market ETF | 49.05K | 0.15% |
Frequently asked questions
Who is the largest shareholder of Nuvectis Pharma?
Tang Capital Management, LLC is the largest institutional shareholder of NVCT, owning 4.75% of shares outstanding (1.55M shares) as of its latest 13F filing.
What percentage of Nuvectis Pharma is owned by institutions?
Institutions own about 33.6% of NVCT shares and 51.2% of the public float.
How much of Nuvectis Pharma do insiders own?
Insiders, such as officers and directors, own about 34.43% of NVCT shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.